$NRXS SEC Filings

On October 14, 2026, the Board of Directors of Neuraxis, Inc. (the “Company”) authorized and the Company declared a stock dividend on the Company’s Series B Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”) for...

Bought 268 shares ($1.3K)

Bought 328 shares ($1.59K)

Bought 1,937 shares ($9.38K)

No securities owned

Received 193,678 shares as a grant or award · Converted 306,236 Stock Options ($2.13M) · Granted 306,236 RSU · 1 more

Received 199,106 shares as a grant or award · Converted 337,204 Stock Options ($2.34M) · Granted 337,204 RSU · 1 more

Received 199,188 shares as a grant or award · Converted 320,000 Stock Options ($2.22M) · Granted 320,000 RSU · 1 more

Received 26,073 shares as a grant or award ($164K)

Granted 133,341 RSU ($837K)

Received 26,073 shares as a grant or award ($164K)

Granted 141,479 RSU ($888K)

Received 31,134 shares as a grant or award ($196K)

Granted 135,906 RSU ($853K)

Granted 193,329 RSU ($1.21M)

Received 42,294 shares as a grant or award · Received 43,930 shares as a grant or award ($276K)